Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-28T17:53:19.124Z Has data issue: false hasContentIssue false

Chapter 6 - Pharmacological Management of Patients with Pelvic Pain

Published online by Cambridge University Press:  08 March 2021

Michael Hibner
Affiliation:
St Joseph’s Hospital & Medical Center, Phoenix, AZ
Get access

Summary

With worsening drug epidemics in the United States, proper pharmacological management in patients with chronic pelvic pain has very significant consequences. It includes chronic management of those patients as well as perioperative management. Multiple nonnarcotic medications have been shown to be very effective in managing patients with pelvic pain. The mainstay of treatment remains nonsteroidal anti-inflammatory medications. They are effective in any type of pain but particularly in dysmenorrhea and inflammatory pain. Anticonvulsants such as gabapentin have been shown to be effective in neuropathic type of pain as well as pre- and postoperative management. Many patients with pelvic pain develop significant pelvic floor muscle spasm. They do not appear to respond well to oral muscle relaxants but usually have very good responses to vaginal suppositories with various combinations of diazepam and other medications. In patients who do not respond to muscle relaxants botulinum toxin injections to pelvic floor muscles may provide muscle relaxation and therefore pain relief. Patients with pain related to nerves may respond to gabapentin and pregabalin but also benefit from use of lidocaine patches. Narcotics pain medications should be used very cautiously and as a last resort.

Type
Chapter
Information
Management of Chronic Pelvic Pain
A Practical Manual
, pp. 50 - 70
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jarrell, JF, Vilos, GA, Allaire, C, Burgess, S, Fortin, C, Gerwin, R, et al. Consensus guidelines for the management of chronic pelvic pain. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2005;27(9):869910.Google Scholar
Fall, M, Baranowski, AP, Elneil, S, Engeler, D, Hughes, J, Messelink, EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):3548.Google Scholar
Royal College of Obstetricians and Gynecologists. The initial management of chronic pelvic pain. Guideline No. 41. 2nd ed.; 2012.Google Scholar
American Pain Society. Pain: Current understanding of assessment, management and treatments. 1st ed; 2001.Google Scholar
Yunker, A, Sathe, NA, Reynolds, WS, Likis, FE, Andrews, J. Systematic review of therapies for noncyclic chronic pelvic pain in women. Obstet Gynecol Surv. 2012;67(7):417–25.CrossRefGoogle ScholarPubMed
Oladosu, FA, Tu, FF, Hellman, KM. Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol. 2018;218(4):390400.Google Scholar
Wong, M, Morris, S, Wang, K, Simpson, K. Managing postoperative pain after minimally invasive gynecologic surgery in the era of the opioid epidemic. J Minim Invasive Gynecol. 2018;25(7):1165–78.Google Scholar
Brown, J, Farquhar, C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014 Mar 10;(3):CD009590.Google Scholar
ACOG (American College of Obstetricians and Gynecologists).Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223–36.Google Scholar
Marjoribanks, J, Ayeleke, RO, Farquhar, C, Proctor, M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul A30;(7):CD001751.Google Scholar
Kroenke, K, Krebs, EE, Bair, MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009;31(3):206–19.Google Scholar
Dowell, D, Haegerich, TM, Chou, R. CDC guideline for prescribing opioids for chronic Pain–United States, 2016. JAMA. 2016;315(15):1624–45.Google Scholar
Furlan, AD, Sandoval, JA, Mailis-Gagnon, A, Tunks, E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ Can Med Assoc J J Assoc Medicale Can. 2006;174(11):1589–94.Google Scholar
Lamvu, G, Feranec, J, Blanton, E. Perioperative pain management: an update for obstetrician-gynecologists. Am J Obstet Gynecol. 2018;218(2):193–9.Google Scholar
Deyo, RA, Hallvik, SE, Hildebran, C, Marino, M, Dexter, E, Irvine, JM, et al. Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naïve patients: a statewide retrospective cohort Study. J Gen Intern Med. 2017;32(1):21–7.Google Scholar
Brummett, CM, Waljee, JF, Goesling, J, Moser, S, Lin, P, Englesbe, MJ, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.CrossRefGoogle ScholarPubMed
Leo, RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(8):2000–8.Google Scholar
Wiffen, PJ, Derry, S, Moore, RA, Aldington, D, Cole, P, Rice, ASC, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013 Nov 11;(11):CD010567.Google Scholar
Wallach, JD, Ross, JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA. 2018;319(8):776–8.CrossRefGoogle ScholarPubMed
Tu, FF, Hellman, KM, Backonja, MM. Gynecologic management of neuropathic pain. Am J Obstet Gynecol. 2011;205(5):435–43.Google Scholar
Moore, RA, Derry, S, Aldington, D, Cole, P, Wiffen, PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015 Jul 6;(7):CD008242.Google ScholarPubMed
Derry, S, Wiffen, PJ, Aldington, D, Moore, RA. Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015 Jan 8;1:CD011209.Google Scholar
Leo, RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(8):2000–8.Google Scholar
Leo, RJ, Dewani, S. A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(10):2497–505.Google Scholar
Goldstein, AT, Pukall, CF, Brown, C, Bergeron, S, Stein, A, Kellogg-Spadt, S. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572–90.Google Scholar
Gallagher, HC, Gallagher, RM, Butler, M, Buggy, DJ, Henman, MC. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015 Aug 23; (8):CD011091.Google Scholar
Lunn, MPT, Hughes, RAC, Wiffen, PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014 Jan 3;(1):CD007115.Google ScholarPubMed
Tofferi, JK, Jackson, JL, O’Malley, PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51(1):913.Google Scholar
Howard, FM. Chronic pelvic pain. Obstet Gynecol. 2003;101(3):594611.Google Scholar
Crisp, CC, Vaccaro, CM, Estanol, MV, Oakley, SH, Kleeman, SD, Fellner, AN, et al. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24(11):1915–23.Google Scholar
Holland, MA, Joyce, JS, Brennaman, LM, Drobnis, EZ, Starr, JA, Foster, RT. Intravaginal diazepam for the treatment of pelvic floor hypertonic disorder: a double-blind, randomized, placebo-controlled trial. Female Pelvic Med Reconstr Surg. 2019;25(1):7681.Google Scholar
Rogalski, MJ, Kellogg-Spadt, S, Hoffmann, AR, Fariello, JY, Whitmore, KE. Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol J. 2010;21(7):895–9.CrossRefGoogle ScholarPubMed
Lee, FC, Holt, SK, Hsi, RS, Haynes, BM, Harper, JD. Preoperative belladonna and opium suppository for ureteral stent pain: a randomized, double-blinded, placebo-controlled study. Urology. 2017;100:2732.Google Scholar
Butler, K, Yi, J, Wasson, M, Klauschie, J, Ryan, D, Hentz, J, et al. Randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery. Am J Obstet Gynecol. 2017;216(5):491.e1–e6.CrossRefGoogle ScholarPubMed
Nibbelink, DW, Strickland, SC, McLean, LF, et al. Cyclobenzaprine, diazepam and placebo in the treatment of skeletal muscle spasm of local origin. Clin Ther. 1978;1(6):409–24.Google Scholar
Carrico, DJ, Peters, KM. Vaginal diazepam use with urogenital pain/pelvic floor dysfunction: serum diazepam levels and efficacy data. Urol Nurs. 2011;31(5):279–84, 299.Google Scholar
Sommer, C, Cruccu, G. Topical treatment of peripheral neuropathic pain: applying the evidence. J Pain Symptom Manage. 2017;53(3):614–29.CrossRefGoogle ScholarPubMed
Attal, N, Cruccu, G, Baron, R, Haanpää, M, Hansson, P, Jensen, TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88.Google Scholar
Derry, S, Rice, AS, Cole, P, Tan, T, Moore, RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017 Jan 13;(1):CD007393.Google ScholarPubMed
Tympanidis, P, Casula, MA, Yiangou, Y, Terenghi, G, Dowd, P, Anand, P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain Lond Engl. 2004;8(2):129–33.Google Scholar
Murina, F, Radici, G, Bianco, V. Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative? Medscape Gen Med. 2004;6(4):48.Google Scholar
Steinberg, AC, Oyama, IA, Rejba, AE, Kellogg-Spadt, S, Whitmore, KE. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol. 2005;192(5):1549–53.Google Scholar
Babbar, S, Marier, J-F, Mouksassi, M-S, Beliveau, M, Vanhove, GF, Chanda, S, et al. Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit. 2009;31(4):502–10.Google Scholar
Cline, AE, Turrentine, JE. Compounded topical analgesics for chronic pain. Dermat Contact Atopic Occup Drug. 2016;27(5):263–71.Google ScholarPubMed
Pickering, G, Martin, E, Tiberghien, F, Delorme, C, Mick, G. Localized neuropathic pain: an expert consensus on local treatments. Drug Des Dev Ther. 2017;11:2709–18.Google Scholar
Derry, S, Wiffen, PJ, Moore, RA, Quinlan, J. Topical lidocaine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014 Jul 24;(7):CD010958.Google Scholar
Binder, A, Rogers, P, Hans, G, Baron, R. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. Pain Manag. 2016;6(3):229–39.Google Scholar
Zolnoun, DA, Hartmann, KE, Steege, JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102(1):84–7.Google Scholar
Zolnoun, DA, Hartmann, KE, Steege, JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102(1):84–7.Google Scholar
Moore, RA, Derry, S, Aldington, D, Cole, P, Wiffen, PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015 Jul 6;(7):CD008242.Google Scholar
Thompson, DF, Brooks, KG. Systematic review of topical amitriptyline for the treatment of neuropathic pain. J Clin Pharm Ther. 2015;40(5):496503.CrossRefGoogle ScholarPubMed
McCleane, G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol. 2000;49(6):574–9.CrossRefGoogle Scholar
Pagano, R, Wong, S. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. J Low Genit Tract Dis. 2012;16(4):394–7.Google Scholar
Derry, S, Wiffen, PJ, Kalso, EA, Bell, RF, Aldington, D, Phillips, T, et al. Topical analgesics for acute and chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 May 12;5:CD008609.Google ScholarPubMed
Ahmed, SU, Zhang, Y, Chen, L, Cohen, A, St Hillary, K, Vo, T, et al. Effect of 1.5% topical diclofenac on clinical neuropathic pain. Anesthesiology. 2015;123(1):191–8.Google Scholar
Dmitrieva, N, Nagabukuro, H, Resuehr, D, Zhang, G, McAllister, SL, McGinty, KA, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151(3):703–10.Google Scholar
Meng, H, Johnston, B, Englesakis, M, Moulin, DE, Bhatia, A. Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis. Anesth Analg. 2017;125(5):1638–52.Google Scholar
Ware, MA, Wang, T, Shapiro, S, Collet, J-P, COMPASS study team. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). J Pain Off J Am Pain Soc. 2015;16(12):1233–42.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×